US FDA

21 CFR 211.122 - Labeling Issuance and Control

Plain-language explanation, inspection context and common violation patterns.

What it says

Labels and labeling must be carefully examined before issuance for use in a labeling operation, strict control must be exercised over labels and labeling to prevent mix-ups, and gang printing of labels for different products or different strengths is only permitted with specific distinguishing features and additional controls.

Paraphrased for plain-language clarity. Always verify against the current published regulation text.

What it means in practice

What FDA inspectors look for

Most common violation

Obsolete label versions remaining physically accessible in a labeling area after a label change, creating a mix-up risk that a purely procedural instruction not to use them does not adequately control.

Related regulations

Want a deeper, interactive breakdown?

GMPify's Regulation Explainer tool gives subscribers an AI-powered analysis of any 21 CFR, EU GMP, USP or ICH reference, with live inspection context.

Try the Regulation Explainer →